Afya Limited Stock Price, News & Analysis

Afya Limited (NASDAQ: AFYA) has completed the acquisition of FACULDADE ÚNICA DE CONTAGEM (FUNIC) for R$100 million. The acquisition adds 60 medical school seats to Afya's portfolio, with operations expected to begin in H2 2025. The payment structure includes R$60 million paid in cash and R$40 million to be paid in three annual CDI-adjusted installments. A contingent consideration provides for an additional payment of R$1 million per seat for up to 60 additional medical school seats if approved by MEC within 36 months. The pre-operational facility is located in Contagem, near Belo Horizonte, Minas Gerais. At full maturity in 2030, Afya projects an EV/EBITDA of 3.3x post-synergies, with expected Net Revenues of R$52.4 million entirely from medical education.

Afya (NASDAQ: AFYA) reported strong financial results for Q4 and full-year 2024. Fourth quarter highlights include:

- Net Revenue up 16.3% YoY to R$849.0 million
- Adjusted EBITDA increased 26.7% YoY to R$366.0 million
- Net Income grew 51.4% YoY to R$154.3 million

Full-year 2024 achievements:

• Net Revenue reached R$3,304.3 million (+14.9% YoY)
• Adjusted EBITDA of R$1,455.6 million (+24.9% YoY)
• Net Income of R$648.9 million (+60.1% YoY)
• Operating Cash Conversion ratio of 102.2%

The company announced its first dividend distribution, with a 20% payout of 2024 net income (R$129.8 million). Afya expanded its medical education footprint through acquisitions and seat additions, reaching 3,653 approved medical school seats. The ecosystem now serves over 313,000 users.

Afya (Nasdaq: AFYA; B3: A2FY34), Brazil's leading medical education group, has announced its first-ever cash dividend distribution of R$129.8 million, representing 20% of the company's R$648.9 million consolidated net income for 2024.

The dividend per share is set at R$1.348923, payable in U.S. dollars on April 4, 2025, to shareholders of record as of March 26, 2025. The payment will be converted using the Brazilian Central Bank's exchange rate of R$/USD 5.8131 published on March 13, 2025.

CFO Luis Blanco emphasized that this distribution demonstrates the company's commitment to shareholder value while maintaining their growth guidance.

Afya (Nasdaq: AFYA; B3: A2FY34) has entered into a share purchase agreement to acquire 100% of Faculdade Única de Contagem (FUNIC) through its subsidiary Afya Participações S.A. The acquisition adds 60 medical school seats in Contagem, Minas Gerais, marking Afya's fifth medical school in the state. The total purchase price is R$ 100 million, with R$ 60 million paid in cash at closing and R$ 40 million in three annual CDI-adjusted installments.

The deal includes potential for 60 additional seats if approved by MEC within 36 months, with R$ 1 million payment per granted seat. At full maturity in 2030, Afya expects an EV/EBITDA of 3.3x with projected Net Revenues of R$ 52.4 million from Medicine operations.

Afya reported strong financial results for Q3 2024, with net revenue increasing 16.3% YoY to R$841.2 million. The company's Adjusted EBITDA grew 25.0% YoY to R$347.9 million, with margin expansion of 290 bps to 41.4%. Net Income rose 26.4% YoY to R$124.1 million. For the nine-month period, net revenue increased 14.4% to R$2,455.3 million, while Adjusted EBITDA grew 24.3% to R$1,089.6 million. The company completed the acquisition of Unidom, adding 300 medical seats, and received authorization for 80 additional seats at UNIMA and 10 seats at Unigranrio, bringing total approved seats to 3,593.

Afya (Nasdaq: AFYA; B3: A2FY34), Brazil's leading medical education group and medical practice solutions provider, has announced it will release its third-quarter and nine months 2024 financial results on November 13th, 2024, after market close. The company will host a conference call and webcast at 05:00 pm EST to discuss the results. Investors can access the webcast through Afya's Investor Relations website and participate via various dial-in numbers provided for Brazil and United States.

Afya (Nasdaq: AFYA; B3: A2FY34), Brazil's leading medical education group and medical practice solutions provider, has announced its upcoming Afya Day 2024 event. Scheduled for October 29th, 2024, the event will be held in a hybrid format, allowing both in-person and online participation.

The event will feature presentations from Afya's executive team, covering the company's growth, business strategy, and future outlook. It will take place from 9:00 a.m. to 12:00 p.m. (São Paulo time) and 8:00 a.m. to 11:00 a.m. (EST).

In-person attendees can join at Afya's São Paulo Flagship location. Due to in-person capacity, early registration is encouraged. Interested participants can register for the event through the provided link on Afya's investor relations website.

Afya (Nasdaq: AFYA; B3: A2FY34), Brazil's leading medical education group and medical practice solutions provider, has announced a commitment to provide 5 million free health consultations by 2030. This initiative aligns with Sustainable Development Goal 3 (SDG 3), which aims to ensure healthy lives and promote well-being for all.

To achieve this goal, Afya plans to expand its network of outpatient clinics from 20 to 27, offering various medical specialties including psychology, physiotherapy, and dentistry. Additionally, the company will incorporate 16 undergraduate units into the Afya Digital Health Network, a telemedicine project facilitating knowledge exchange among professors, students, and preceptors.

Virgilio Gibbon, Afya's CEO and SDG 3 Impact Leader, emphasized the company's commitment to aligning business objectives with meaningful purpose, generating lasting impact on served populations, and promoting long-term improvements in community health and quality of life.

Afya (Nasdaq: AFYA; B3: A2FY34), Brazil's leading medical education group, has announced a positive outcome from the Ministry of Education (MEC) regarding Universidade do Grande Rio Professor José de Souza Herdy (Unigranrio). The MEC has granted Unigranrio's request for reconsideration, resulting in the reestablishment of 10 medical seats in Rio de Janeiro. This decision brings Unigranrio's total medical seats to 318 across both campuses. Consequently, Afya's total approved medical seats have increased to 3,593. This development underscores Afya's commitment to excellence in medical education and reinforces its position as a leading medical education provider in Brazil.